Innovation, Future of Medicine Key Themes for BIO 2005
WASHINGTON, D.C. (March 29, 2005) -- Innovation will be the key medical and scientific theme at the Biotechnology Industry Organization (BIO) 2005 Annual International Convention as researchers from around the world discuss new ways to predict, treat, and someday cure some of man’s most intractable diseases. The meeting will take place in Philadelphia, June 19-22, 2005 at the Philadelphia Convention Center.
“The mapping of the human genome has given us a new starting point to analyze how diseases work and how best to research new therapies,” said Jim Greenwood, president of BIO. “Nanotechnology, personalized medicine, new approaches to obesity and cancer – this convention will cover the spectrum of biotechnology innovation.
“With biotechnology, new innovative therapies for age old diseases are being researched every day. This new dynamic industry has already developed unique therapies for cancer, multiple sclerosis, arthritis, heart attacks, and strokes – just to name a few. More than 800 million people have already benefited from these and other new biotech therapies.
“This event is expected to be the most highly attended convention in Philadelphia since the National Republican Convention of 2000,” concluded Greenwood.
BIO 2005 will feature dozens of sessions on drug discovery and development; vaccines; nanotechnology, pharmacogenomics and other cutting-edge technologies; and biotech approaches to meeting unmet medical needs.
More than 18,000 biotech executives, investors, journalists, policy makers and scientists from more than 60 countries are expected to attend. The full program, which includes more than 150 educational sessions and workshops on topics including industrial and environmental applications, finance, science, manufacturing, and food and agriculture, as well as over 1,000 speakers, is available at www.bio.org/events/2005/. Sample medical and science sessions include:
Science and Medicine
Monday, June 20
Navigating the New Frontier of Science and Technology – 9:30am – 10:45am
The Finnegan Henderson 2005 Biotechnology Innovation Report– 9:30am – 10:45am
Cancer Vaccines Come of Age – 4:00pm – 5:30pm
Revolutionizing Identification and Treatment of Infectious Diseases – 4:00pm – 5:30pm
New, Innovative Adolescent Vaccines Create Immunization Opportunities - 2:15pm – 3:45pm
Tuesday, June 21
Biomarkers for Disease and Toxicity: Current and the Future – 9:30am – 10:45am
Getting Ahead of the Bugs: The New Anti-Infectives – 11:00am – 12:15pm
Next-Generation Biopharmaceuticals: Improved Therapy and Reduced Cost – 11:00am – 12:15pm
The Convergence of Biologics and Devices in Treating Serious Heart Disease - 11:00am – 12:15pm
Pharmacogenomics and Personalized Medicine – 4:00pm – 5:30pm
Wednesday, June 22
Bringing Regenerative Medicine to the Clinic: Cardiovascular Disease as a Case Study – 9:30am – 10:45am
Stem Cells for Treatment of Neurological Diseases - 11:00am – 12:15pm
All Roads Lead to Inflammation—New Avenues for Discovery and Development – 2:15pm – 3:45pm
Targeted Therapies in Cancer: Delivering the Promise - 2:15pm – 3:45pm
Changing Regulatory Environment for Anti-Obesity Drug Development – 2:15pm – 3:45pm
Advance media registration for BIO 2005 is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit www.bio.org/events/2005/ . Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers and online publications must register in advance by June 10, 2005.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.
###